Amanote Research
Register
Sign In
Augmenting Nomogram to Predict Malignancy in Pancreatic IPMN by Using SUVmax
HPB
- United Kingdom
doi 10.1016/j.hpb.2018.06.1936
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Gastroenterology
Date
September 1, 2018
Authors
H.K. Hwang
C.M. Kang
D.S. Yoon
W.J. Lee
Publisher
Elsevier BV
Related search
A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors
Clinical Cancer Research
Cancer Research
Oncology
IPMN Involving the Main Pancreatic Duct
Annals of Surgery
Surgery
Preoperative Nomogram to Predict Survival for Patients With Resectable and Borderline Resectable Pancreatic Cancer
HPB
Hepatology
Gastroenterology
Precise Gene Analysis of Pancreatic Ductal Carcinoma Derived From IPMN and Concomitant With IPMN Using Resected Tissue and Pancreatic Exocrine Secretions
Suizo
The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy
Clinical Genitourinary Cancer
Oncology
Urology
A Nomogram to Predict Overall Survival for Biliary Tract Cancer
Cancer Management and Research
Oncology
Preoperative Nomogram to Predict the Likelihood of Complications After Radical Nephroureterectomy
BJU International
Urology
A Nomogram to Predict Lymph Node Metastasis in Patients With Early Gastric Cancer
Oncotarget
Oncology
A Nomogram to Predict the Incident Radiographic Knee Osteoarthritis in a Chinese Rural Area
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
